A detailed history of Abound Wealth Management transactions in Insulet Corp stock. As of the latest transaction made, Abound Wealth Management holds 8 shares of PODD stock, worth $2,120. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8
Previous 8 -0.0%
Holding current value
$2,120
Previous $1.62 Million 15.29%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Aug 08, 2024

SELL
$127.77 - $221.42 $255 - $442
-2 Reduced 20.0%
8 $1.74 Million
Q3 2023

Aug 08, 2024

BUY
$154.67 - $290.89 $309 - $581
2 Added 25.0%
10 $1.6 Million
Q1 2023

Aug 07, 2024

BUY
$276.36 - $326.03 $2,210 - $2,608
8 New
8 $2.55 Million

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.4B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Abound Wealth Management Portfolio

Follow Abound Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abound Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Abound Wealth Management with notifications on news.